MicroRNA-155 modulates the proliferation of vascular smooth muscle cells by targeting endothelial nitric oxide synthase

International Journal of Molecular Medicine

Volumn 35, Issue 6, 2015, Pages 1708-1714

  Zhang, Jun ^a   Zhao, Fei ^a   Yu, Xiaoling ^a   Lu, Xiang ^a   Zheng, Guofeng ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Atherosclerosis; Endothelial nitric oxide synthase; MiR 155; Vascular smooth muscle cell

Indexed keywords

CYCLIC GMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; MESSENGER RNA; MICRORNA 1; MICRORNA 145; MICRORNA 146A; MICRORNA 155; MICRORNA 21; MICRORNA 221; MICRORNA 26A; MICRORNA; MIRN155 MICRORNA, HUMAN; NOS3 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ADULT; APOPTOSIS; ARTICLE; ATHEROSCLEROTIC PLAQUE; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DOWN REGULATION; ENZYME ACTIVITY; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN RNA BINDING; PROTEIN TARGETING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; VASCULAR SMOOTH MUSCLE CELL; WESTERN BLOTTING; BIOSYNTHESIS; CELL CULTURE; ENZYMOLOGY; GENE EXPRESSION REGULATION; METABOLISM; PATHOLOGY; SMOOTH MUSCLE CELL; VASCULAR SMOOTH MUSCLE;

APOPTOSIS; CELL PROLIFERATION; CELLS, CULTURED; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MALE; MICRORNAS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NITRIC OXIDE SYNTHASE TYPE III; PLAQUE, ATHEROSCLEROTIC;

EID: 84928385436     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2015.2181     Document Type: Article

References (39)

1. Pidkovka NA, Cherepanova OA, Yoshida T, Alexander MR, Deaton RA, Thomas JA, Leitinger N and Owens GK: Oxidized phospholipids induce phenotypic switching of vascular smooth muscle cells in vivo and in vitro. Circ Res 101: 792-801, 2007
2. Berliner JA and Watson AD: A role for oxidized phospholipids in atherosclerosis. N Engl J Med 353: 9-11, 2005
3. Libby P, Ridker PM and Hansson GK: Progress and challenges in translating the biology of atherosclerosis. Nature 473: 317-325, 2011
4. Lacolley P, Regnault V, Nicoletti A, Li Z and Michel JB: The vascular smooth muscle cell in arterial pathology: A cell that can take on multiple roles. Cardiovasc Res 95: 194-204, 2012
5. Hata A: Functions of microRNAs in cardiovascular biology and disease. Annu Rev Physiol 75: 69-93, 2013
6. Kang H and Hata A: MicroRNA regulation of smooth muscle gene expression and phenotype. Curr Opin Hematol 19: 224-231, 2012
7. McDonald RA, Hata A, MacLean MR, Morrell NW and Baker AH: MicroRNA and vascular remodelling in acute vascular injury and pulmonary vascular remodelling. Cardiovasc Res 93: 594-604, 2012
8. Cheng Y, Liu X, Yang J, Lin Y, Xu DZ, Lu Q, Deitch EA, Huo Y, Delphin ES and Zhang C: MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circ Res 105: 158-166, 2009
9. Cordes KR, Sheehy NT, White MP, Berry EC, Morton SU, Muth AN, Lee TH, Miano JM, Ivey KN and Srivastava D: miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 460: 705-710, 2009
10. Davis BN, Hilyard AC, Nguyen PH, Lagna G and Hata A: Induction of microRNA-221 by platelet-derived growth factor signaling is critical for modulation of vascular smooth muscle phenotype. J Biol Chem 284: 3728-3738, 2009
11. Liu X, Cheng Y, Zhang S, Lin Y, Yang J and Zhang C: A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Circ Res 104: 476-487, 2009
12. Wang M, Li W, Chang GQ, Ye CS, Ou JS, Li XX, Liu Y, Cheang TY, Huang XL and Wang SM: MicroRNA-21 regulates vascular smooth muscle cell function via targeting tropomyosin 1 in arteriosclerosis obliterans of lower extremities. Arterioscler Thromb Vasc Biol 31: 2044-2053, 2011
13. Chan MC, Hilyard AC, Wu C, Davis BN, Hill NS, Lal A, Lieberman J, Lagna G and Hata A: Molecular basis for antagonism between PDGF and the TGFbeta family of signalling pathways by control of miR-24 expression. EMBO J 29: 559-573, 2010
14. Ji R, Cheng Y, Yue J, Yang J, Liu X, Chen H, Dean DB and Zhang C: MicroRNA expression signature and antisense-mediated depletion reveal an essential role of microRNA in vascular neointimal lesion formation. Circ Res 100: 1579-1588, 2007
15. Sun SG, Zheng B, Han M, Fang XM, Li HX, Miao SB, Su M, Han Y, Shi HJ and Wen JK: miR-146a and Krüppel-like factor 4 form a feedback loop to participate in vascular smooth muscle cell proliferation. EMBO Rep 12: 56-62, 2011
16. Zhang E and Wu Y: Dual effects of miR-155 on macrophages at different stages of atherosclerosis: LDL is the key? Med Hypotheses 83: 74-78, 2014
17. Tian FJ, An LN, Wang GK, Zhu JQ, Li Q, Zhang YY, Zeng A, Zou J, Zhu RF, Han XS, et al: Elevated microRNA-155 promotes foam cell formation by targeting HBP1 in atherogenesis. Cardiovasc Res 103: 100-110, 2014
18. Hao L, Wang XG, Cheng JD, You SZ, Ma SH, Zhong X, Quan L and Luo B: The up-regulation of endothelin-1 and down-regulation of miRNA-125a-5p,-155, and-199a/b-3p in human atherosclerotic coronary artery. Cardiovasc Pathol 23: 217-223, 2014
19. Weber M, Kim S, Patterson N, Rooney K and Searles CD: MiRNA-155 targets myosin light chain kinase and modulates actin cytoskeleton organization in endothelial cells. Am J Physiol Heart Circ Physiol 306: H1192-H1203, 2014
20. Sun HX, Zeng DY, Li RT, Pang RP, Yang H, Hu YL, Zhang Q, Jiang Y, Huang LY, Tang YB, et al: Essential role of microRNA-155 in regulating endothelium-dependent vasorelaxation by targeting endothelial nitric oxide synthase. Hypertension 60: 1407-1414, 2012
21. Zhang LN, Wilson DW, da Cunha V, Sullivan ME, Vergona R, Rutledge JC and Wang YX: Endothelial NO synthase deficiency promotes smooth muscle progenitor cells in association with upregulation of stromal cell-derived factor-1alpha in a mouse model of carotid artery ligation. Arterioscler Thromb Vasc Biol 26: 765-772, 2006
22. Boyle JJ, Weissberg PL and Bennett MR: Tumor necrosis factor-Alpha promotes macrophage-induced vascular smooth muscle cell apoptosis by direct and autocrine mechanisms. Arterioscler Thromb Vasc Biol 23: 1553-1558, 2003
23. Gough PJ, Gomez IG, Wille PT and Raines EW: Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice. J Clin Invest 116: 59-69, 2006
24. Ishida N, Hayashi K, Hattori A, Yogo K, Kimura T and Takeya T: CCR1 acts downstream of NFAT2 in osteoclastogenesis and enhances cell migration. J Bone Miner Res 21: 48-57, 2006
25. Erl W, Hristov M, Neureuter M, Yan ZQ, Hansson GK and Weber PC: HMG-CoA reductase inhibitors induce apoptosis in neointima-derived vascular smooth muscle cells. Atherosclerosis 169: 251-258, 2003
26. Fichtlscherer S, De Rosa S, Fox H, Schwietz T, Fischer A, Liebetrau C, Weber M, Hamm CW, Röxe T, Müller-Ardogan M, et al: Circulating microRNAs in patients with coronary artery disease. Circ Res 107: 677-684, 2010
27. Raitoharju E, Lyytikäinen LP, Levula M, Oksala N, Mennander A, Tarkka M, Klopp N, Illig T, Kähönen M, Karhunen PJ, et al: miR-21, miR-210, miR-34a, and miR-146a/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular Study. Atherosclerosis 219: 211-217, 2011
28. Nazari-Jahantigh M, Wei Y, Noels H, Akhtar S, Zhou Z, Koenen RR, Heyll K, Gremse F, Kiessling F, Grommes J, et al: MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages. J Clin Invest 122: 4190-4202, 2012
29. Martin MM, Buckenberger JA, Jiang J, Malana GE, Nuovo GJ, Chotani M, Feldman DS, Schmittgen TD and Elton TS: The human angiotensin II type 1 receptor +1166 A/C polymorphism attenuates microRNA-155 binding. J Biol Chem 282: 24262-24269, 2007
30. O'Connell RM, Taganov KD, Boldin MP, Cheng G and Baltimore D: MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci USA 104: 1604-1609, 2007
31. Zhu N, Zhang D, Chen S, Liu X, Lin L, Huang X, Guo Z, Liu J, Wang Y, Yuan W, et al: Endothelial enriched microRNAs regulate angiotensin II-induced endothelial inflammation and migration. Atherosclerosis 215: 286-293, 2011
32. Ceppi M, Pereira PM, Dunand-Sauthier I, Barras E, Reith W, Santos MA and Pierre P: MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells. Proc Natl Acad Sci USA 106: 2735-2740, 2009
33. Taganov KD, Boldin MP, Chang KJ and Baltimore D: NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA 103: 12481-12486, 2006
34. Graff JW, Dickson AM, Clay G, McCaffrey AP and Wilson ME: Identifying functional microRNAs in macrophages with polarized phenotypes. J Biol Chem 287: 21816-21825, 2012
35. Heeneman S, Sluimer JC and Daemen MJ: Angiotensin-converting enzyme and vascular remodeling. Circ Res 101: 441-454, 2007
36. Donners MM, Wolfs IM, Stöger LJ, van der Vorst EP, Pöttgens CC, Heymans S, Schroen B, Gijbels MJ and de Winther MP: Hematopoietic miR155 deficiency enhances atherosclerosis and decreases plaque stability in hyperlipidemic mice. PLoS One 7: e35877, 2012
37. Naseem KM: The role of nitric oxide in cardiovascular diseases. Mol Aspects Med 26: 33-65, 2005
38. Albrecht EW, Stegeman CA, Heeringa P, Henning RH and van Goor H: Protective role of endothelial nitric oxide synthase. J Pathol 199: 8-17, 2003
39. Casscells W: Migration of smooth muscle and endothelial cells. Critical events in restenosis. Circulation 86: 723-729, 1992.